NO823291L - Aminooksazolylforbindelser, fremgangsmaate til deres fremstilling, farmasoeytiske preparater som inneholder de og preparatenes anvendelse - Google Patents

Aminooksazolylforbindelser, fremgangsmaate til deres fremstilling, farmasoeytiske preparater som inneholder de og preparatenes anvendelse

Info

Publication number
NO823291L
NO823291L NO823291A NO823291A NO823291L NO 823291 L NO823291 L NO 823291L NO 823291 A NO823291 A NO 823291A NO 823291 A NO823291 A NO 823291A NO 823291 L NO823291 L NO 823291L
Authority
NO
Norway
Prior art keywords
hydroxy
substituted
compounds
mercapto
preparations
Prior art date
Application number
NO823291A
Other languages
English (en)
Norwegian (no)
Inventor
Riccardo Scartazzini
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO823291L publication Critical patent/NO823291L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO823291A 1981-09-30 1982-09-29 Aminooksazolylforbindelser, fremgangsmaate til deres fremstilling, farmasoeytiske preparater som inneholder de og preparatenes anvendelse NO823291L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH630381 1981-09-30
CH304982 1982-05-17
CH480782 1982-08-11

Publications (1)

Publication Number Publication Date
NO823291L true NO823291L (no) 1983-04-05

Family

ID=27174099

Family Applications (1)

Application Number Title Priority Date Filing Date
NO823291A NO823291L (no) 1981-09-30 1982-09-29 Aminooksazolylforbindelser, fremgangsmaate til deres fremstilling, farmasoeytiske preparater som inneholder de og preparatenes anvendelse

Country Status (12)

Country Link
EP (1) EP0076452A3 (fr)
DD (1) DD204256A5 (fr)
DK (1) DK432582A (fr)
ES (1) ES516013A0 (fr)
FI (1) FI823304L (fr)
GB (1) GB2106519B (fr)
GR (1) GR77677B (fr)
MA (1) MA19602A1 (fr)
NO (1) NO823291L (fr)
PT (1) PT75626B (fr)
RO (1) RO84457B (fr)
ZW (1) ZW20982A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3377061D1 (en) * 1982-06-03 1988-07-21 Hoffmann La Roche Process for the preparation of 1-sulfo-2-oxoazetidine derivatives
JPS6197288A (ja) * 1984-10-19 1986-05-15 Kaken Pharmaceut Co Ltd セフアロスポリン化合物
US4698338A (en) * 1986-02-19 1987-10-06 Eli Lilly And Company 7[2-(2-aminothiazol-4-yl)-2-benzyloximino]acetamido-3[4-alkyl-5-oxo-6-hydroxy-3,4-dihydro-1,2,4-triazin-3-yl]thiomethyl cephalosporins
HUT53892A (en) * 1989-04-07 1990-12-28 Technologishen Kom Za Promy Mi Process for producing synaminothiazolyl and synaminooxazolyl derivatives
US20110118462A1 (en) * 2009-11-18 2011-05-19 Guangzhou Baiyunshan Pharmaceutical Co., Ltd. Guangzhou Baiyunshan Pharmaceutical Factory N-heterocyclic substituent-containing antibiotic, preparation and use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH557381A (de) * 1967-04-15 1974-12-31 Fujisawa Pharmaceutical Co Verfahren zur herstellung von (delta)3-cephemverbindungen.
FR2068419A1 (en) * 1969-10-27 1971-08-27 Fujisawa Pharmaceutical Co Antibacterial cephalosporin compsns
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
CA1088049A (fr) * 1975-06-03 1980-10-21 Takashi Masugi Procedes d'obtention de derives d'acides alcanamido substitues en 3 et substitues en 7-3-cephem-4 carboxyliques
US4382931A (en) * 1981-09-08 1983-05-10 Eli Lilly And Company 3'-Substituted quinolinium cephalosporins
US4430499A (en) * 1981-09-08 1984-02-07 Eli Lilly And Company 7-[2-(2-Aminooxazol-4-yl)-2-(oximino)acetamido]cephalosporin antibiotics
US4382932A (en) * 1981-09-08 1983-05-10 Eli Lilly And Company Isoquinolinium substituted cephalosporins
US4379787A (en) * 1981-10-02 1983-04-12 Eli Lilly And Company Oximino-substituted cephalosporin compounds
US4388316A (en) * 1981-10-02 1983-06-14 Eli Lilly And Company Amino-substituted oxazole, oxadiazole and isoxazole-substituted cephalosporins
DE3377061D1 (en) * 1982-06-03 1988-07-21 Hoffmann La Roche Process for the preparation of 1-sulfo-2-oxoazetidine derivatives

Also Published As

Publication number Publication date
EP0076452A3 (fr) 1984-09-05
FI823304A7 (fi) 1983-03-31
MA19602A1 (fr) 1983-04-01
DK432582A (da) 1983-03-31
ES8402592A1 (es) 1984-02-01
PT75626B (de) 1985-12-09
FI823304A0 (fi) 1982-09-27
ES516013A0 (es) 1984-02-01
GB2106519B (en) 1985-04-24
RO84457A (fr) 1984-06-21
ZW20982A1 (en) 1983-04-27
FI823304L (fi) 1983-03-31
EP0076452A2 (fr) 1983-04-13
PT75626A (de) 1982-10-01
DD204256A5 (de) 1983-11-23
GR77677B (fr) 1984-09-25
GB2106519A (en) 1983-04-13
RO84457B (ro) 1984-08-30

Similar Documents

Publication Publication Date Title
JPS5412381A (en) N-alkylpiperidine derivative
NL980012I2 (nl) Mometasonfuroaat-monohydraat, werkwijze om zulks te bereiden en farmaceutische samenstellingen.
DK518683A (da) Fremgangsmaade til fremstilling af 4aeepi-9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a eller farmaceutisk acceptable syreadditionssalte deraf og mellemprodukter ved fremgangsmaaden
AU565168B2 (en) 4:-demethyl - 4 - epipodophyllotoxin derivatives
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
DK304682A (da) Vandholdigt topisk praeparat og fremgangsmaade til formindskelse af vandtab fra saadanne praeparater
NO971625L (no) Nye peptider med immunomodulatoriske effekter
IT7826811A0 (it) Antibiotici prodotti mediante nuove speci di nocardia.
ES8504977A1 (es) Procedimiento para preparar -monohidrato de (+)-catequina.
ES459406A1 (es) Un procedimiento para la preparacion de un compuesto de pi- perazinilpirazina.
IE851204L (en) Beta-carbolines
ES8606374A1 (es) Un procedimiento para preparar derivados de acido neuramini-co
DK0583578T3 (da) 17-(3-furyl)- og 17-(4-pyridazinyl)-5beta,14beta-androstanderivater med aktivitet på det cardiovaskulære system, fremgangsmåder til deres fremstilling og farmaceutiske præparater indeholdende disse
ATE35812T1 (de) Gamma-butyrolactonderivate, verfahren zur herstellung derselben und dieselben als aktive bestandteile enthaltende immunomodulierende zubereitungen.
GB1125820A (en) The uses of glutamic acid derivatives as preservatives
NO950665L (no) Nye polyjoderte forbindelser, fremgangsmåte for deres fremstilling og kontrastmidler inneholdende disse
AU563990B2 (en) Hexahydropyrrolo (2,1-a) isoquinoline derivatives
DE3461378D1 (en) Rifamycins derivatives and preparation and pharmaceutical compositions thereof
GB2020659B (en) Derivatives of 1,5-dimethylbicyclo (3.2.1) octane
ES8201993A1 (es) Un procedimiento para la preparacion de tiazoles
DK0457215T3 (da) 3-deamino-4-desoxy-4-amino-8-fluoranthracycliner samt fremgangsmåder til fremstilling deraf
ES425628A1 (es) Procedimiento de preparacion de derivados de piperidina sustituidos con amino.
DK140152B (da) Fremgangsmåde til fremstilling af et antibioticum kaldet fortimicin C eller syreadditionssalte deraf.
GB1465583A (en) Imidazo 4,5-b-pyridine derivatives
ES8107179A1 (es) Procedimiento de preparacion de nuevos productos sulfurados con grupo amida, que derivan de la anilina